Chen C N, Andrade J D
J Pharm Sci. 1976 May;65(5):717-24. doi: 10.1002/jps.2600650522.
An extension of the Bischoff-Dedrick pharmacokinetic model is presented. This model is derived from basic considerations of drug distrubition with physiological and anatomical meaning. The Bischoff-Dedrick model can simultaneously predict drug distribution with time in blood, organs, and tissues of pharmacological interest. The parameters are applied to a 15-kg standard dog. The experimental kinetic data of thiopental in brain, plasma, liver, lean tissue, and adipose tissue in a dog are used to demonstrate the feasibility of the model. Allowable variations in the parameters are determined. In general, the kinetics of drug distribution in blood, organs, and tissues depend on the drug dosage, lipid solubility, partition coefficients, metabolism rate, excretion rate, protein binding, route of administration, sizes of organs and tissues, and blood flow rates through organs and tissues. These factors enter the kinetic model separately and explicitly so their effects on the kinetics of drug distribution can be studied to provide valuable information for optimal therapy.
本文提出了Bischoff-Dedrick药代动力学模型的扩展。该模型源自对具有生理和解剖学意义的药物分布的基本考量。Bischoff-Dedrick模型能够同时预测药物在血液、器官以及具有药理活性的组织中随时间的分布情况。这些参数应用于一只15千克的标准犬。犬脑、血浆、肝脏、瘦组织和脂肪组织中硫喷妥钠的实验动力学数据用于证明该模型的可行性。确定了参数的允许变化范围。一般来说,药物在血液、器官和组织中的分布动力学取决于药物剂量、脂溶性、分配系数、代谢率、排泄率、蛋白质结合、给药途径、器官和组织的大小以及通过器官和组织的血流速率。这些因素分别且明确地纳入动力学模型,因此可以研究它们对药物分布动力学的影响,为优化治疗提供有价值的信息。